Cargando…
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?
Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder. Various autoimmune diseases, including AHA, have been reported to occur after the administration of mRNA COVID-19 vaccines. However, the characteristics of these AHA cases remain unclear. We report a case in which AHA arose in a you...
Autores principales: | Hosoi, Hiroki, Tane, Misato, Kosako, Hideki, Ibe, Masaki, Takeyama, Masahiro, Murata, Shogo, Mushino, Toshiki, Sonoki, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485432/ https://www.ncbi.nlm.nih.gov/pubmed/36155279 http://dx.doi.org/10.1016/j.jaut.2022.102915 |
Ejemplares similares
-
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases
por: Hosoi, Hiroki, et al.
Publicado: (2022) -
Severe systemic inflammation mimicking TAFRO syndrome following COVID-19
por: Tane, Misato, et al.
Publicado: (2023) -
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?
por: Tabata, Shotaro, et al.
Publicado: (2022) -
Administration of combined venetoclax and azacitidine in a patient with acute myeloid leukemia and multiple comorbidities undergoing dialysis: A case report
por: Akagi, Yuina, et al.
Publicado: (2023) -
Rituximab Monotherapy for Grade 2-3 Lymphomatoid Granulomatosis with Central Nervous System Involvement in a Patient Receiving Methotrexate for Rheumatoid Arthritis
por: Hosoi, Hiroki, et al.
Publicado: (2022)